A critical advance in cancer study is arising with the use of mini-antibodies to re-engage mutated p53. This vital cancer suppressor protein is frequently disabled in many types of cancer, resulting uncontrolled cell https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research